ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,296,101 | +22.1% | 27,696 | +82.8% | 0.00% | 0.0% |
| Q2 2023 | $2,699,579 | -85.5% | 15,150 | -86.6% | 0.00% | -81.8% |
| Q1 2023 | $18,673,472 | +11.0% | 113,200 | +5.9% | 0.01% | 0.0% |
| Q4 2022 | $16,828,470 | -9.3% | 106,861 | -13.3% | 0.01% | -15.4% |
| Q3 2022 | $18,564,010 | +570.1% | 123,267 | +631.5% | 0.01% | +550.0% |
| Q2 2022 | $2,770,136 | -26.2% | 16,851 | -0.1% | 0.00% | 0.0% |
| Q1 2022 | $3,755,269 | -29.9% | 16,867 | -25.3% | 0.00% | -33.3% |
| Q4 2021 | $5,357,000 | -0.1% | 22,571 | -1.8% | 0.00% | -25.0% |
| Q3 2021 | $5,364,000 | +20.5% | 22,984 | +6.2% | 0.00% | 0.0% |
| Q2 2021 | $4,453,000 | -1.9% | 21,639 | -2.0% | 0.00% | 0.0% |
| Q1 2021 | $4,538,000 | -10.2% | 22,087 | -6.3% | 0.00% | -20.0% |
| Q4 2020 | $5,054,000 | +8.2% | 23,564 | -7.8% | 0.01% | 0.0% |
| Q3 2020 | $4,670,000 | -0.3% | 25,551 | -1.7% | 0.01% | +25.0% |
| Q2 2020 | $4,684,000 | -15.8% | 26,000 | -5.7% | 0.00% | -33.3% |
| Q1 2020 | $5,563,000 | +10.0% | 27,571 | +2.0% | 0.01% | +20.0% |
| Q4 2019 | $5,056,000 | +13.2% | 27,018 | -5.4% | 0.01% | 0.0% |
| Q3 2019 | $4,468,000 | -35.1% | 28,565 | +4.5% | 0.01% | -37.5% |
| Q2 2019 | $6,885,000 | +5.7% | 27,330 | +0.4% | 0.01% | +14.3% |
| Q1 2019 | $6,514,000 | +1.1% | 27,218 | -3.0% | 0.01% | -12.5% |
| Q4 2018 | $6,444,000 | -17.3% | 28,060 | +1.8% | 0.01% | 0.0% |
| Q3 2018 | $7,795,000 | +7.4% | 27,568 | +11.5% | 0.01% | 0.0% |
| Q2 2018 | $7,260,000 | -18.6% | 24,722 | -30.0% | 0.01% | -20.0% |
| Q1 2018 | $8,916,000 | +255.9% | 35,326 | +204.5% | 0.01% | +233.3% |
| Q4 2017 | $2,505,000 | +18.7% | 11,603 | +2.2% | 0.00% | 0.0% |
| Q3 2017 | $2,111,000 | +6.7% | 11,358 | -1.0% | 0.00% | +50.0% |
| Q2 2017 | $1,979,000 | +14.5% | 11,468 | +1.3% | 0.00% | 0.0% |
| Q1 2017 | $1,728,000 | +17.8% | 11,322 | +13.8% | 0.00% | 0.0% |
| Q4 2016 | $1,467,000 | +16.4% | 9,951 | -0.1% | 0.00% | 0.0% |
| Q3 2016 | $1,260,000 | +13.2% | 9,963 | +0.9% | 0.00% | 0.0% |
| Q2 2016 | $1,113,000 | -77.4% | 9,872 | -79.0% | 0.00% | -50.0% |
| Q1 2016 | $4,924,000 | -6.7% | 46,985 | +0.4% | 0.00% | -20.0% |
| Q4 2015 | $5,275,000 | +3.2% | 46,779 | +0.2% | 0.01% | 0.0% |
| Q3 2015 | $5,112,000 | -10.5% | 46,684 | -21.8% | 0.01% | -28.6% |
| Q2 2015 | $5,710,000 | +2.6% | 59,696 | -0.1% | 0.01% | 0.0% |
| Q1 2015 | $5,564,000 | +14.3% | 59,737 | +0.5% | 0.01% | 0.0% |
| Q4 2014 | $4,868,000 | +764.7% | 59,437 | +577.5% | 0.01% | +600.0% |
| Q3 2014 | $563,000 | +9.7% | 8,773 | +4.0% | 0.00% | 0.0% |
| Q2 2014 | $513,000 | -12.6% | 8,433 | -14.0% | 0.00% | 0.0% |
| Q1 2014 | $587,000 | -6.2% | 9,809 | -0.2% | 0.00% | 0.0% |
| Q4 2013 | $626,000 | -7.0% | 9,833 | -0.7% | 0.00% | 0.0% |
| Q3 2013 | $673,000 | -84.2% | 9,906 | -83.3% | 0.00% | -87.5% |
| Q2 2013 | $4,271,000 | – | 59,262 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |